62-73-7

62-73-7结构式
62-73-7结构式
  • 常用中文名:敌敌畏
  • 常用英文名:Dichlorvos
  • CAS号:62-73-7
  • 分子式:C4H7Cl2O4P
  • 分子量:220.976
  • 相关类别: 原料药 其它化学药 卫生防疫用药
  • 发布时间:2018-02-03 08:00:00
  • 更新时间:2024-01-02 18:18:26
  • 用途一:敌敌畏具有熏蒸、胃毒和触杀作用,对咀嚼式口器害虫和刺吸式口器害虫均有良好的防效。敌敌畏的蒸气压较高,对害虫有很强的击倒力。施用后易分解、残效期短。使用方法多种多样,简便易行。适用于防治棉花、果树、蔬菜、甘蔗、烟草、茶、桑等作物上的多种害虫。对蚊、蝇等家庭卫生害虫以及仓库害虫米象、谷盗等也有良好的防治效果。
    用途二:高效、广谱杀虫剂,具有胃毒、触杀和强烈的熏蒸作用,由于蒸气压较高,对咀嚼口器和刺吸口器害虫具有很强的击倒力。主要用于防治卫生害虫,农林,园艺害虫,粮仓害虫,如:蚊、蝇、咀、孑孓、臭虫、蟑螂、黑尾叶蝉、黏虫、蚜虫、红蜘蛛、水稻浮尘子、食心虫、梨星毛虫、桑蟥、桑粉虱、桑尺蠖、茶蚕、茶毛虫、马尾松毛虫、柳青蛾、青虫、黄条跳甲、菜螟、造桥虫、斜纹夜蛾、苹果巢蛾等。用药量为80%乳油1000~2000倍液喷雾。对高梁易产生药害,对豆类、玉米、柳树也较敏感。
    用途三:具有熏蒸、胃毒和触杀作用,对咀嚼口器害虫和刺吸口器害虫均有良好的防治效果
    用途四:可用作家庭和公共场所的熏蒸剂,也适用于防治棉花、果树、蔬菜、烟、茶、桑等作物上的多害虫
     

化源商城直购

中文名 敌敌畏
英文名 dichlorvos
中文别名 2,2-二氯乙烯基二甲基磷酸酯
DDVP乳剂
O,O-二甲基-O-(2,2-二氯)乙烯基磷酸酯
杀虫快油雾剂
英文别名 Task
DDVP
Mafu
MFCD00036123
Herka
PIRAN
NUVAN
DDVF
OKO
2,2-dichlorovinyl dimethyl phosphate
EINECS 200-547-7
Nuva
Dichlorvos
UDVF
dichlorovos
密度 1.4±0.1 g/cm3
沸点 176.8±40.0 °C at 760 mmHg
熔点 -60°C
分子式 C4H7Cl2O4P
分子量 220.976
闪点 14.7±35.0 °C
精确质量 219.945908
PSA 54.57000
LogP 0.71
外观性状 一种芳香无色至琥珀色液体
蒸汽压 1.4±0.3 mmHg at 25°C
折射率 1.461
储存条件

储存注意事项储存于阴凉、通风的库房。远离火种、热源。保持容器密封。应与氧化剂、碱类、食用化学品分开存放,切忌混储。配备相应品种和数量的消防器材。储区应备有泄漏应急处理设备和合适的收容材料。

稳定性

1.对热稳定,但能水解,饱和水溶液在室温24h分解3%,在碱性溶液或沸水中1h可完全水解。水解产物为磷酸氢二甲酯和二氯乙醛。

2.稳定性 稳定

3.禁配物 强氧化剂、强碱

4.避免接触的条件 受热

5.聚合危害 不聚合

6.分解产物 氯化氢、氧化磷

水溶解性 略溶于水. 1 G/100 ML
分子结构

1、摩尔折射率:42.28

2、摩尔体积(cm3/mol):153.9

3、等张比容(90.2K):382.6

4、表面张力(dyne/cm):38.1

5、极化率(10-24cm3):16.76

计算化学

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:0

3.氢键受体数量:4

4.可旋转化学键数量:4

5.互变异构体数量:无

6.拓扑分子极性表面积44.8

7.重原子数量:11

8.表面电荷:0

9.复杂度:181

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

更多

1.性状:纯品是无色有芳香气味的液体。有挥发性。

2.熔点(℃):<25

3.沸点(℃):140(2.6kPa)

4.相对密度(水=1):1.425(25℃)

5.相对蒸气密度(空气=1):7.5

6.饱和蒸气压(kPa):0.001(20℃)

7.辛醇/水分配系数:1.43

8.闪点(℃):79.4

9.溶解性:微溶于水,易溶于乙醇、芳烃等多数有机溶剂。

第一部分:化学品名称
化学品中文名称: 敌敌畏
化学品英文名称: Dichlorvos;DDVP
中文俗名或商品名:
Synonyms:
CAS No.: 62-73-7
分子式: C4H7Cl2O4P
分子量: 220.99
第二部分:成分/组成信息
纯化学品混合物
化学品名称:敌敌畏
有害物成分 含量 CAS No.
敌敌畏 100 62-73-7
第三部分:危险性概述
危险性类别: 第6.1类 毒害品
侵入途径: 吸入 食入 经皮吸收
健康危害: 抑制体内胆碱酯酶,造成神经生理功能紊乱。急性中毒多系误服引起。中毒表现有头痛、头昏、食欲减退、恶心、呕吐,腹痛、腹泻、流涎、瞳孔缩小、呼吸道分泌物增多、多汗、肌束震颤等。重症出现肺水肿、昏迷、呼吸麻痹、脑水肿。血胆碱酯酶活性降低。少数重度中毒者在临床症状消失后数周出现周围神经病。本品可引起变应性接触性皮炎。慢性中毒:接触工人可因持续经呼吸道及皮肤进入而中毒。表现有头晕、头痛、无力、失眠、多
环境危害: 对环境有危害,对水体和大气可造成污染。
燃爆危险: 本品可燃,有毒,具刺激性。
第四部分:急救措施
皮肤接触: 立即脱去污染的衣着,用肥皂水及流动清水彻底冲洗污染的皮肤、头发、指甲等。就医。
眼睛接触: 立即提起眼睑,用流动清水冲洗lo分钟或用2%碳酸氢钠溶液冲洗。
吸入: 迅速脱离现场至空气新鲜处。呼吸困难时给输氧。呼吸停止时,立即进行人工呼吸。就医。
食入: 误服者给饮大量温水,催吐,可用温水或1:5000高锰酸钾液彻底洗胃。或用2%碳酸氢钠反复洗胃。就医。
第五部分:消防措施
危险特性: 遇明火、高热可燃。与强氧化剂可发生反应。受热分解,放出氧化磷和氯化物的毒性气体。
有害燃烧产物: 一氧化碳、二氧化碳、氯化氢、氧化磷。
灭火方法及灭火剂: 雾状水、泡沫、二氧化碳、砂土。
消防员的个体防护: 消防人员须佩戴防毒面具、穿全身消防服,在上风向灭火。
禁止使用的灭火剂:
闪点(℃): 无资料
自燃温度(℃): 无资料
爆炸下限[%(V/V)]: 无资料
爆炸上限[%(V/V)]: 无资料
最小点火能(mJ):
爆燃点:
爆速:
最大燃爆压力(MPa):
建规火险分级:
第六部分:泄漏应急处理
应急处理: 疏散泄漏污染区人员至安全区,禁止无关人员进入污染区,切断火源。建议应急处理人员戴自给式呼吸器,穿化学防护服。不要直接接触泄漏物,在确保安全情况下堵漏。喷水雾会减少蒸发,但不能降低泄漏物在受跟制空间内的易燃性。用沙土或其它不燃性吸附剂混合吸收,然后转移到安全场所。也可以用大量水冲洗,经稀释的洗水放入废水系统。如大量泄漏,利用围堤收容,然后收集、转移、回收或无害处理后废弃。
第七部分:操作处置与储存
操作注意事项: 密闭操作,提供充分的局部排风。操作尽可能机械化、自动化。操作人员必须经过专门培训,严格遵守操作规程。建议操作人员佩戴自吸过滤式防毒面具(全面罩),穿胶布防毒衣,戴橡胶手套。远离火种、热源,工作场所严禁吸烟。使用防爆型的通风系统和设备。防止蒸气泄漏到工作场所空气中。避免与氧化剂、碱类接触。搬运时要轻装轻卸,防止包装及容器损坏。配备相应品种和数量的消防器材及泄漏应急处理设备。倒空的容器可能残留有害物。
储存注意事项: 储存于阴凉、通风的库房。远离火种、热源。保持容器密封。应与氧化剂、碱类、食用化学品分开存放,切忌混储。配备相应品种和数量的消防器材。储区应备有泄漏应急处理设备和合适的收容材料。
第八部分:接触控制/个体防护
最高容许浓度: 中国MAC:0.3mg/m3[皮]苏联MAC:0.2mg/m3[皮]美国TWA:ACGIH
监测方法: 2,4-二硝基苯肼比色法;气相色谱法
工程控制: 严加密闭,提供充分的局部排风。尽可能机械化、自动化。
呼吸系统防护: 生产操作或农业使用时,佩带防毒口罩。紧急事态抢救或逃生时,应该佩带自给式呼吸器。
眼睛防护: 戴化学安全防护眼镜。
身体防护: 穿相应的防护服。
手防护: 戴防护手套。
其他防护: 工作现场禁止吸烟、进食和饮水。工作后,彻底清洗。工作服不要带到非作业场所,单独存放被毒物污染的衣服,
第九部分:理化特性
外观与性状: 钝品为无色油状液体,微带刺激性气味。
pH:
熔点(℃): 无资料
沸点(℃): 74/0.13kPa
相对密度(水=1): 1.42
相对蒸气密度(空气=1): 无资料
饱和蒸气压(kPa): 0.02/20℃
燃烧热(kJ/mol):
临界温度(℃):
临界压力(MPa):
辛醇/水分配系数的对数值:
闪点(℃): 无资料
引燃温度(℃): 无资料
爆炸上限%(V/V): 无资料
爆炸下限%(V/V): 无资料
分子式: C4H7Cl2O4P
分子量: 220.99
蒸发速率:
粘性:
溶解性: 微溶于水,易溶于醇、芳烃等。
主要用途: 用作农药杀虫剂。
第十部分:稳定性和反应活性
稳定性: 在常温常压下 稳定
禁配物: 强氧化剂、强碱。
避免接触的条件:
聚合危害: 不能出现
分解产物: 一氧化碳、二氧化碳、氯化氢、氧化磷。
第十一部分:毒理学资料
急性毒性: 属中等毒类 LD50:50~80mg/kg(大鼠经口);113mg/kg(大鼠经皮) LC50:5mg/m3 4小时(大鼠吸入)
急性中毒:
慢性中毒:
亚急性和慢性毒性:
刺激性:
致敏性:
致突变性:
致畸性:
致癌性:
第十二部分:生态学资料
生态毒理毒性:
生物降解性:
非生物降解性:
生物富集或生物积累性:
第十三部分:废弃处置
废弃物性质:
废弃处置方法: 处置前应参阅国家和地方有关法规。建议用焚烧法处置。与燃料混合后,再焚烧。焚烧炉排出的气体要通过洗涤器除去。
废弃注意事项:
第十四部分:运输信息
危险货物编号: 61875
UN编号: 3018
包装标志:
包装类别:
包装方法: 塑料袋或二层牛皮纸袋外全开口或中开口钢桶;两层塑料袋或一层塑料袋外麻袋、塑料编织袋、乳胶布袋;塑料袋外复合塑料编织袋(聚丙烯三合一袋、聚乙烯三合一袋、聚丙烯二合一袋、聚乙烯二合一袋);塑料袋或二层牛皮纸袋外普通木箱;螺纹口玻璃瓶、塑料瓶、复合塑料瓶或铝瓶外普通木箱;塑料瓶、两层塑料袋或两层牛皮纸袋(内或外套以塑料袋)外瓦楞纸箱。
运输注意事项: 运输前应先检查包装容器是否完整、密封,运输过程中要确保容器不泄漏、不倒塌、不坠落、不损坏。严禁与酸类、氧化剂、食品及食品添加剂混运。运输时运输车辆应配备相应品种和数量的消防器材及泄漏应急处理设备。运输途中应防曝晒、雨淋,防高温。公路运输时要按规定路线行驶。
RETCS号:
IMDG规则页码:
第十五部分:法规信息
国内化学品安全管理法规: 化学危险物品安全管理条例 (1987年2月17日国务院发布),化学危险物品安全管理条例实施细则 (化劳发[1992] 677号),工作场所安全使用化学品规定 ([1996]劳部发423号)等法规,针对化学危险品的安全使用、生产、储存、运输、装卸等方面均作了相应规定;常用危险化学品的分类及标志 (GB 13690-92)将该物质划为第6.1 类毒害品。其它法规:敌敌畏生产安全技术规定 (HGA032-83)。
国际化学品安全管理法规:
第十六部分:其他信息
参考文献: 1.周国泰,化学危险品安全技术全书,化学工业出版社,1997 2.国家环保局有毒化学品管理办公室、北京化工研究院合编,化学品毒性法规环境数据手册,中国环境科学出版社.1992 3.Canadian Centre for Occupational Health and Safety,CHEMINFO Database.1998 4.Canadian Centre for Occupational Health and Safety, RTECS Database, 1989
填表时间: 年月日
填表部门:
数据审核单位:
修改说明:
其他信息: 2
MSDS修改日期: 年月日

毒理学数据:

1.急性毒性

LD50:50~80mg/kg(大鼠经口);113mg/kg(大鼠经皮)

LC50:15mg/m3(大鼠吸入,4h)

2.刺激性 暂无资料

3.亚急性与慢性毒性 兔经口剂量在0.2mg/(kg·d)以上时,经24周,引起慢性中毒,超过1mg/(kg·d),动物肝肾发生严重病变,ChE持续下降。

4.致突变性 微生物致突变性:鼠伤寒沙门菌330μg/皿。DNA抑制:人类淋巴细胞100μl。精子形态学改变:小鼠腹腔35mg/kg(5d)。

5.致畸性 猪孕后41~70d经口给予最低中毒剂量(TDLo)255mg/kg,致中枢神经系统、血液和淋巴系统(包括脾和骨髓)、内分泌系统发育畸形。大鼠孕后11d腹腔内给予最低中毒剂量(TDLo)15mg/kg,致体壁发育畸形。

6.致癌性 IARC致癌性评论:G2B,可疑人类致癌物。大鼠经口最低中毒剂量(TDLo):4120mg/kg(2a,连续),致癌,肺肿瘤、胃肠肿瘤。小鼠经皮最低中毒剂量(TDLo):20600mg/kg(2a,连续),致癌,胃肠肿瘤。

7.其他 大鼠经口最低中毒剂量(TDLo):39.2mg/kg(孕14~21d),致新生鼠生化和代谢改变。

生态学数据:

1.生态毒性

LC50:1250ppb/96(大西洋月银汉鱼,静态);1000ppm/24h(蓝鳃太阳鱼)

EC50:0.00007mg/L(48h)(水蚤)

2.生物降解性 暂无资料

3.非生物降解性 空气中,当羟基自由基浓度为5.00×105个/cm3时,降解半衰期为7.25h。

4.其他有害作用 该物质对环境有危害,对水体和大气可造成污染,对鱼类、蜜蜂和鸟类应给予特别注意。对蔬菜、土壤中和水中生物也应给予特别注意。

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TC0350000
CHEMICAL NAME :
Phosphoric acid, 2,2-dichlorovinyl dimethyl ester
CAS REGISTRY NUMBER :
62-73-7
BEILSTEIN REFERENCE NO. :
1709141
LAST UPDATED :
199806
DATA ITEMS CITED :
153
MOLECULAR FORMULA :
C4-H7-Cl2-O4-P
MOLECULAR WEIGHT :
220.98
WISWESSER LINE NOTATION :
GYGU1OPO&O1&O1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
17 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LC50 - Lethal concentration, 50 percent kill
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
15 mg/m3/4H
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation Behavioral - tremor Gastrointestinal - changes in structure or function of salivary glands
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
750 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
15 mg/kg
TOXIC EFFECTS :
Brain and Coverings - other degenerative changes Blood - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
10800 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
57 mg/kg
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
61 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LC50 - Lethal concentration, 50 percent kill
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
13 mg/m3/4H
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation Behavioral - tremor Gastrointestinal - changes in structure or function of salivary glands
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
206 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
22 mg/kg
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
24 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Sense Organs and Special Senses (Eye) - effect, not otherwise specified Lungs, Thorax, or Respiration - dyspnea
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
18 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
75 mg/kg
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
2200 ug/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Gastrointestinal - hypermotility, diarrhea Gastrointestinal - nausea or vomiting
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Autonomic Nervous System - other (direct) parasympathomimetic Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
107 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
23 mg/kg
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - pig
DOSE/DURATION :
157 mg/kg
TOXIC EFFECTS :
Gastrointestinal - nausea or vomiting Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - hamster
DOSE/DURATION :
30 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - pigeon
DOSE/DURATION :
23700 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - chicken
DOSE/DURATION :
6450 ug/kg
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - quail
DOSE/DURATION :
22010 ug/kg
TOXIC EFFECTS :
Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Gastrointestinal - hypermotility, diarrhea
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - duck
DOSE/DURATION :
7800 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
125 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - wild bird species
DOSE/DURATION :
12 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
360 mg/kg/90D-I
TOXIC EFFECTS :
Liver - other changes Blood - other changes Biochemical - Metabolism (Intermediary) - lipids including transport
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
56 mg/kg/14D-I
TOXIC EFFECTS :
Liver - other changes Kidney, Ureter, Bladder - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other hydrolases
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
45 mg/kg/6W-I
TOXIC EFFECTS :
Brain and Coverings - changes in surface EEG Peripheral Nerve and Sensation - recording from peripheral motor nerve Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
8200 ug/m3/45D-I
TOXIC EFFECTS :
Nutritional and Gross Metabolic - weight loss or decreased weight gain Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
141 mg/kg/17W-I
TOXIC EFFECTS :
Brain and Coverings - other degenerative changes Liver - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
28 mg/kg/28D-I
TOXIC EFFECTS :
Liver - other changes Nutritional and Gross Metabolic - weight loss or decreased weight gain Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
21600 ug/kg/17W-I
TOXIC EFFECTS :
Liver - other changes Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis) Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
5200 mg/kg/13W-I
TOXIC EFFECTS :
Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
750 mg/kg/10D-I
TOXIC EFFECTS :
Blood - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
400 mg/kg/4D-I
TOXIC EFFECTS :
Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - chicken
DOSE/DURATION :
2450 mg/kg/28D-C
TOXIC EFFECTS :
Brain and Coverings - other degenerative changes Nutritional and Gross Metabolic - weight loss or decreased weight gain Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
4120 mg/kg/2Y-C
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors Gastrointestinal - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2060 mg/kg/2Y-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Gastrointestinal - tumors Blood - leukemia
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
20600 mg/kg/2Y-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Gastrointestinal - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
39200 ug/kg
SEX/DURATION :
female 14-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - biochemical and metabolic
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
220 mg/kg
SEX/DURATION :
multigeneration
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain) Reproductive - Effects on Newborn - physical Reproductive - Effects on Newborn - delayed effects
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
15 mg/kg
SEX/DURATION :
female 11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
40 mg/kg
SEX/DURATION :
male 2 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count) Reproductive - Paternal Effects - testes, epididymis, sperm duct
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
180 mg/kg
SEX/DURATION :
male 18 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
65 mg/kg
SEX/DURATION :
female 6-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
60 mg/kg
SEX/DURATION :
female 22-31 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - biochemical and metabolic
TYPE OF TEST :
TCLo - Lowest published toxic concentration
ROUTE OF EXPOSURE :
Inhalation
DOSE :
4 mg/m3/23H
SEX/DURATION :
female 1-28 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
60 mg/kg
SEX/DURATION :
female 22-31 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - biochemical and metabolic
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
255 mg/kg
SEX/DURATION :
female 41-70 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - blood and lymphatic systems (including spleen and marrow) Reproductive - Specific Developmental Abnormalities - endocrine system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
759 mg/kg
SEX/DURATION :
female 1-15 week(s) after conception lactating female 4 week(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - biochemical and metabolic
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
90 mg/kg
SEX/DURATION :
female 42-44 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
TYPE OF TEST :
Sex chromosome loss and nondisjunction
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
DNA damage
TYPE OF TEST :
DNA damage
TYPE OF TEST :
Sperm Morphology
TYPE OF TEST :
Cytogenetic analysis

MUTATION DATA

TYPE OF TEST :
DNA damage
TEST SYSTEM :
Mammal - species unspecified Lymphocyte
REFERENCE :
NATWAY Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1913- Volume(issue)/page/year: 57,393,1970 *** REVIEWS *** ACGIH TLV-Not classifiable as a human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 0.90 mg/m3 (0.1 ppm) (skin) DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 53,267,1991 IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 20,97,1979 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 20,97,1979 IARC Cancer Review:Human Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 53,267,1991 IARC Cancer Review:Group 2B IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 53,267,1991 TOXICOLOGY REVIEW RREVAH Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- Volume(issue)/page/year: 46,1,1973 TOXICOLOGY REVIEW MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 32,133,1975 TOXICOLOGY REVIEW CNDQA8 Cahiers de Nutrition et de Dietetique. (Editions Meteore, 42, rue du Louvre, 75001 Paris, France) V.1- 1966- Volume(issue)/page/year: 10(3),43,1975 TOXICOLOGY REVIEW NYZZA3 Nippon Yakuzaishikai Zasshi. Journal of the Japan Pharmaceutical Association. (Nippon Yakuznishikai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1949- Volume(issue)/page/year: 26,739,1974 TOXICOLOGY REVIEW NWSCAL New Scientist. (IPC Magazines Ltd., King's Reach Tower, Stamford St., London SE1 9LS, UK) V.1- 1956- Volume(issue)/page/year: 53,489,1972 TOXICOLOGY REVIEW RREVAH Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1962- Volume(issue)/page/year: 63,1,1976 TOXICOLOGY REVIEW ALLVAR Alimentation et la Vie. (Societe Scientifique d'Hygiene Alimentaire, 16, rue de l'Estrapade, 75005 Paris, France) V.39- 1951- Volume(issue)/page/year: 50,77,1962 *** U.S. STANDARDS AND REGULATIONS *** EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION FEREAC Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- Volume(issue)/page/year: 54,7740,1989 MSHA STANDARD-air:TWA 0.1 ppm (1.0 mg/m3) DTLWS* "Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For publisher information, see 85INA8. Volume(issue)/page/year: 3,16,1973 OSHA PEL (Gen Indu):8H TWA 1 mg/m3 (skin) CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):8H TWA 1 mg/m3 (skin) CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):8H TWA 1 mg/m3 (skin) CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-ARAB Republic of Egypt:TWA 0.1 ppm (1 mg/m3) JAN 1993 OEL-AUSTRALIA:TWA 0.1 ppm (1 mg/m3);Skin JAN 1993 OEL-AUSTRIA:TWA 0.1 ppm (1 mg/m3);Skin JAN 1993 OEL-BELGIUM:TWA 01 ppm (0.9 mg/m3);Skin JAN 1993 OEL-DENMARK:TWA 0.1 ppm (1 mg/m3);Skin JAN 1993 OEL-FINLAND:TWA 1 mg/m3;STEL 3 mg/m3;Skin JAN 1993 OEL-FRANCE:TWA 0.1 ppm (1 mg/m3);Skin JAN 1993 OEL-GERMANY:TWA 0.1 ppm (1 mg/m3);Skin JAN 1993 OEL-HUNGARY:STEL 0.2 mg/m3;Skin JAN 1993 OEL-INDIA:TWA 0.1 ppm (1 mg/m3);Skin JAN 1993 OEL-THE NETHERLANDS:TWA 0.1 ppm (1 mg/m3);Skin JAN 1993 OEL-THE PHILIPPINES:TWA 1 mg/m3;Skin JAN 1993 OEL-POLAND:TWA 1 mg/m3 JAN 1993 OEL-RUSSIA:STEL 0.2 mg/m3;Skin JAN 1993 OEL-SWITZERLAND:TWA 0.1 ppm (1 mg/m3);Skin JAN 1993 OEL-THAILAND JAN 1993 OEL-UNITED KINGDOM:TWA 0.1 ppm (1 mg/m3);STEL 0.3 ppm;Skin JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO DICHLORVOS-air:10H TWA 1 mg/m3 (Sk) REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - M0377 No. of Facilities: 2139 (estimated) No. of Industries: 16 No. of Occupations: 20 No. of Employees: 29515 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - M0377 No. of Facilities: 1356 (estimated) No. of Industries: 10 No. of Occupations: 17 No. of Employees: 24205 (estimated) No. of Female Employees: 2466 (estimated)

符号 GHS06 GHS09
GHS06, GHS09
信号词 Danger
危害声明 H300 + H310 + H330-H317-H400
警示性声明 P260-P280-P284-P301 + P310 + P330-P302 + P352 + P310-P304 + P340 + P310
个人防护装备 Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
危害码 (欧洲) T:Toxic
风险声明 (欧洲) R24/25;R26;R43;R50
安全声明 (欧洲) 1/2-28-36/37-45-61
危险品运输编码 2786
WGK德国 3
RTECS号 TC0350000
包装等级 II
危险类别 6.1(a)
海关编码 29141100

~%

62-73-7结构式

62-73-7

文献:US4464308 A1, ;

~%

62-73-7结构式

62-73-7

文献:Journal of the American Chemical Society, , vol. 77, p. 2424,2426 Journal of the American Chemical Society, , vol. 77, p. 2554 Chem.Abstr., , p. 393 Trudy 1. Konf.fosfororg. Soedin. Kazan 1955 S. 50, 60 DE1003720 , ; Journal of Agricultural and Food Chemistry, , vol. 3, p. 319 US2865943 , ;

~%

62-73-7结构式

62-73-7

文献:Journal of the American Chemical Society, , vol. 77, p. 2424,2426 Journal of the American Chemical Society, , vol. 77, p. 2871,2874 Chemische Berichte, , vol. 87, p. 755,757

~%

62-73-7结构式

62-73-7

详细
文献:J. Gen. Chem. USSR (Engl. Transl.), , vol. 58, # 9 p. 2063 - 2066,1839 - 1841

~%

62-73-7结构式

62-73-7

文献:J. Gen. Chem. USSR (Engl. Transl.), , vol. 56, # 12 p. 2700 - 2702,2389 - 2391

~%

62-73-7结构式

62-73-7

文献:Chemische Berichte, , vol. 87, p. 755,757

~%

62-73-7结构式

62-73-7

文献:Chemische Berichte, , vol. 87, p. 755,757

1.由敌百虫在溶剂中经碱解制得。

2.由亚磷酸三甲酯与三氯乙醛进行珀考夫重排缩合制得。

3.由敌百虫在溶剂中经碱解制得,反应结束静置分层,油层经薄膜蒸发回收溶剂,并得敌敌畏原油。或者由亚磷酸三甲酯与三氯乙醛进行柏尔柯夫(Perkow)重排缩合制得。

4.脱氯化氢法:敌百虫在碱性条件下脱氯化氢生成敌敌畏。操作时控制敌百虫水悬浮液含量为25%(也可用精制敌百虫母液,加适量的敌百虫固体),敌百虫与碱的配比为1∶(1.35~1.4),采用水和甲苯(二甲苯、苯)两个溶剂,反应温度50~60℃,反应时间20~25min,终点pH值7~8。这一反应使α-羟基膦酸酯重排成磷酸酯。反应结束静置分层,油层经薄膜蒸发回收溶剂,并得敌敌畏原油。

5.制备或来源:在搅拌下,将熔融的敌百虫和水加入碱解釜中,在加入溶剂苯,然后加入30%液碱,在约2~3分钟内加完,温度不超过65℃,控制PH值,如酸性即补加碱,加完后搅拌0.5小时,将反应物送入分液器静置15~30min,分去水层,苯层再静置15min,进一步分去水,所得敌敌畏苯油在减压下加热,流经薄膜蒸发器,脱去苯和水,得原油。也可采用亚磷酸三甲酯与三氯乙醛进行珀考夫重排缩合制得,亚磷酸三甲酯由三氯化磷与甲醇反应制得。制剂有:原油,50%、80%乳油,50%油剂,20%塑料块缓释剂,15%缓释颗粒。
备注:残効期短。饱和的敌敌畏水溶液转化成磷酸氢二甲酯和二氯乙醛,其水解速度每天约3%,在碱性溶液中水解更快。对铁和软钢有腐蚀性,但对不锈钢、铝、镍、Hastelloy13和Teflon无腐蚀性。对热稳定。雄、雌大白鼠急性经口毒性LD50分别为80、56mg/kg,雄、雌大白鼠急性经皮毒性LD50分别为107、75mg/kg。鲤鱼LC50为4mg/L。米、麦、杂粮、果实、蔬菜、茶允许残留量为0.1mg/kg,草莓为0.3mg/kg。ADI为0.03mg/kg。

海关编码 2919900090
中文概述 HS:2919900090 其他磷酸酯及其盐(包括乳磷酸盐)(包括它们的卤化,磺化,硝化和亚硝化衍生物) 增值税率:17.0% 退税率:9.0% 监管条件:AB(入境货物通关单,出境货物通关单) 最惠国关税:6.5% 普通关税:30.0%
申报要素 品名, 成分含量, 用途
监管条件 A.入境货物通关单 B.出境货物通关单
检验检疫 R.进口食品卫生监督检验 S.出口食品卫生监督检验 M.进口商品检验 N.出口商品检验
Summary 2919900090 other phosphoric esters and their salts, including lactophosphates; their halogenated, sulphonated, nitrated or nitrosated derivatives。supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward)。VAT:17.0%。tax rebate rate:9.0%。MFN tariff:6.5%。general tariff:30.0%